High frequency of vertebral fracture and low bone quality in patients with rheumatoid arthritis—Results from TOMORROW study

References

• Kroot EJ, Nieuwenhuizen MG, de Waal Malefijt MC, van Riel PL, Pasker-de Jong PC, Laan RF. Change in bone mineral density in patients with rheumatoid arthritis during the first decade of the disease. Arthritis Rheum. 2001;44:1254–60.
   PubMed Web of Science ®Google Scholar
• Gough AK, Lilley J, Eyre S, Holder RL, Emery P. Generalised bone loss in patients with early rheumatoid arthritis. Lancet. 1994;344:23–7.
   PubMed Web of Science ®Google Scholar
• Deodhar AA, Woolf AD. Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol. 1996;35:309–22.
   PubMedGoogle Scholar
• Lodder MC, Haugeberg G, Lems WF, Uhlig T, Orstavik RE, Kostense PJ, et al. Radiographic damage associated with low bone mineral density and vertebral deformities in rheumatoid arthritis: the Oslo-Truro-Amsterdam (OSTRA) collaborative study. Arthritis Rheum. 2003;49:209–15.
   PubMed Web of Science ®Google Scholar
• Haugeberg G, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone mineral density and frequency of osteoporosis in female patients with rheumatoid arthritis: results from 394 patients in the Oslo county rheumatoid arthritis register. Arthritis Rheum. 2000;43:522–30.
   PubMed Web of Science ®Google Scholar
• Matuszewska A, Szechiński J. Evaluation of selected bone metabolism markers in rheumatoid arthritis patients. Adv Clin Exp Med. 2013;22:193–202.
   PubMed Web of Science ®Google Scholar
• Cortet B, Flipo RM, Pigny P, Duquesnoy B, Racadot A, Boersma A, et al. How useful are bone turnover markers in rheumatoid arthritis? Influence of disease activity and corticosteroid therapy. Rev Rhum Engl Ed. 1997;64:153–9.
   PubMedGoogle Scholar
• Suzuki K, Tsuji S, Fukushima Y, Nakase T, Hamada M, Tomita T, et al. Clinical results of alendronate monotherapy and combined therapy with menatetrenone (VitK2) in postmenopausal RA patients. Mod Rheumatol. 2013;23:450–5.
   PubMed Web of Science ®Google Scholar
• Mokuda S, Okuda Y, Onishi M, Sawada N, Matoba K, Yamada A, et al. Post-menopausal women with rheumatoid arthritis who are treated with raloxifene or alendronate or glucocorticoids have lower serum undercarboxylated osteocalcin levels. J Endocrinol Invest. 2012;35:661–4.
   PubMed Web of Science ®Google Scholar
• Hein GE, Köhler M, Oelzner P, Stein G, Franke S. The advanced glycation end product pentosidine correlates to IL-6 and other relevant inflammatory markers in rheumatoid arthritis. Rheumatol Int. 2005;26:137–41.
   PubMed Web of Science ®Google Scholar
• Chen JR, Takahashi M, Suzuki M, Kushida K, Miyamoto S, Inoue T. Comparison of the concentrations of pentosidine in the synovial fluid, serum and urine of patients with rheumatoid arthritis and osteoarthritis. Rheumatology (Oxford). 1999;38:1275–8.
   PubMed Web of Science ®Google Scholar
• Takahashi M, Kushida K, Ohishi T, Kawana K, Hoshino H, Uchiyama A, et al. Quantitative analysis of crosslinks pyridinoline and pentosidine in articular cartilage of patients with bone and joint disorders. Arthritis Rheum. 1994;37:724–8.
   PubMed Web of Science ®Google Scholar
• Ørstavik RE, Haugeberg G, Mowinckel P, Høiseth A, Uhlig T, Falch JA, et al. Vertebral deformities in rheumatoid arthritis: a comparison with population-based controls. Arch Intern Med. 2004;164:420–5.
   PubMedGoogle Scholar
• Dirven L, van den Broek M, van Groenendael JH, de Beus WM, Kerstens PJ, Huizinga TW, et al. Prevalence of vertebral fractures in a disease activity steered cohort of patients with early active rheumatoid arthritis. BMC Musculoskelet Disord. 2012;13:125.
   PubMed Web of Science ®Google Scholar
• Vis M, Haavardsholm EA, Bøyesen P, Haugeberg G, Uhlig T, Hoff M, et al. High incidence of vertebral and non-vertebral fractures in the OSTRA cohort study: a 5-year follow-up study in postmenopausal women with rheumatoid arthritis. Osteoporos Int. 2011;22:2413–19.
   PubMed Web of Science ®Google Scholar
• Arnett FC, Edworthy SM, Bloch DA, McShane DJ, Fries JF, Cooper NS, et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 1988;31:315–24.
   PubMed Web of Science ®Google Scholar
• Prevoo ML, van 't Hof MA, Kuper HH, van Leeuwen MA, van de Putte LB, van Riel PL. Modified disease activity scores that include twenty-eight-joint counts. Development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum. 1995;38:44–8.
   PubMed Web of Science ®Google Scholar
• Felsenberg D, Wieland E, Gowin W, Armbrecht G, Bolze X, Khorassani A, et al. Morphometric analysis of roentgen images of the spine for diagnosis of osteoporosis-induced fracture. Med Klin (Munich). 1998;93 (Suppl 2):26–30.
   Google Scholar
• Eastell R, Nagase S, Small M, Boonen S, Spector T, Ohyama M, et al. Effect of ONO-5334 on bone mineral density and biochemical markers of bone turnover in postmenopausal osteoporosis: 2-year results from the OCEAN study. J Bone Miner Res. 2014;29:458–66.
   PubMed Web of Science ®Google Scholar
• McCloskey EV, Spector TD, Eyres KS, Fern ED, O'Rourke N, Vasikaran S, et al. The assessment of vertebral deformity: a method for use in population studies and clinical trials. Osteoporos Int. 1993;3:138–47.
   PubMed Web of Science ®Google Scholar
• Genant HK, Wu CY, van Kuijk C, Nevitt MC. Vertebral fracture assessment using a semiquantitative technique. J Bone Miner Res. 1993;8:1137–48.
   PubMed Web of Science ®Google Scholar
• Nishizawa Y, Ohta H, Miura M, Inaba M, Ichimura S, Shiraki M, et al. Guidelines for the use of bone metabolic markers in the diagnosis and treatment of osteoporosis (2012 edition). J Bone Miner Metab. 2013;31:1–15.
   PubMed Web of Science ®Google Scholar
• Laan RF, Buijs WC, Verbeek AL, Draad MP, Corstens FH, van de Putte LB, et al. Bone mineral density in patients with recent onset rheumatoid arthritis: influence of disease activity and functional capacity. Ann Rheum Dis. 1993;52:21–6.
   PubMed Web of Science ®Google Scholar
• Hall GM, Spector TD, Griffin AJ, Jawad AS, Hall ML, Doyle DV. The effect of rheumatoid arthritis and steroid therapy on bone density in postmenopausal women. Arthritis Rheum. 1993;36:1510–16.
   PubMed Web of Science ®Google Scholar
• Haugeberg G, Ørstavik RE, Uhlig T, Falch JA, Halse JI, Kvien TK. Bone loss in patients with rheumatoid arthritis: results from a population-based cohort of 366 patients followed up for two years. Arthritis Rheum. 2002;46:1720–8.
   PubMed Web of Science ®Google Scholar
• Ochi K, Furuya T, Ikari K, Taniguchi A, Yamanaka H, Momohara S. Sites, frequencies, and causes of self-reported fractures in 9,720 rheumatoid arthritis patients: a large prospective observational cohort study in Japan. Arch Osteoporos. 2013;8:130.
   PubMed Web of Science ®Google Scholar
• Shenstone BD, Mahmoud A, Woodward R, Elvins D, Palmer R, Ring EF, et al. Longitudinal bone mineral density changes in early rheumatoid arthritis. Br J Rheumatol. 1994;33:541–5.
   PubMedGoogle Scholar
• Cortet B, Guyot MH, Solau E, Pigny P, Dumoulin F, Flipo RM, et al. Factors influencing bone loss in rheumatoid arthritis: a longitudinal study. Clin Exp Rheumatol. 2000;18:683–90.
   PubMed Web of Science ®Google Scholar
• Forslind K, Keller C, Svensson B, Hafström I, and Group BS. Reduced bone mineral density in early rheumatoid arthritis is associated with radiological joint damage at baseline and after 2 years in women. J Rheumatol. 2003;30:2590–6.
   PubMed Web of Science ®Google Scholar
• Jensen T, Klarlund M, Hansen M, Jensen KE, Pødenphant J, Hansen TM, et al. Bone loss in unclassified polyarthritis and early rheumatoid arthritis is better detected by digital X ray radiogrammetry than dual x ray absorptiometry: relationship with disease activity and radiographic outcome. Ann Rheum Dis. 2004;63:15–22.
   PubMed Web of Science ®Google Scholar
• El Maghraoui A, Rezqi A, Mounach A, Achemlal L, Bezza A, Ghozlani I. Prevalence and risk factors of vertebral fractures in women with rheumatoid arthritis using vertebral fracture assessment. Rheumatology (Oxford). 2010;49:1303–10.
   PubMed Web of Science ®Google Scholar
• van Staa TP, Geusens P, Bijlsma JW, Leufkens HG, Cooper C. Clinical assessment of the long-term risk of fracture in patients with rheumatoid arthritis. Arthritis Rheum. 2006;54:3104–12.
   PubMed Web of Science ®Google Scholar
• Kim SY, Schneeweiss S, Liu J, Daniel GW, Chang CL, Garneau K, et al. Risk of osteoporotic fracture in a large population-based cohort of patients with rheumatoid arthritis. Arthritis Res Ther. 2010;12:R154.
   PubMed Web of Science ®Google Scholar
• Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK. Osteoporos Int. 2008;19:385–97.
   PubMed Web of Science ®Google Scholar
• Aonuma H, Miyakoshi N, Hongo M, Kasukawa Y, Shimada Y. Low serum levels of undercarboxylated osteocalcin in postmenopausal osteoporotic women receiving an inhibitor of bone resorption. Tohoku J Exp Med. 2009;218:201–5.
   PubMed Web of Science ®Google Scholar
• Vergnaud P, Garnero P, Meunier PJ, Bréart G, Kamihagi K, Delmas PD. Undercarboxylated osteocalcin measured with a specific immunoassay predicts hip fracture in elderly women: the EPIDOS Study. J Clin Endocrinol Metab. 1997;82:719–24.
   PubMed Web of Science ®Google Scholar
• Yasui T, Uemura H, Tomita J, Miyatani Y, Yamada M, Miura M, et al. Association of serum undercarboxylated osteocalcin with serum estradiol in pre-, peri- and early post-menopausal women. J Endocrinol Invest. 2006;29:913–18.
   PubMed Web of Science ®Google Scholar
• Robins SP, Bailey AJ. The chemistry of the collagen cross-links. Characterization of the products of reduction of skin, tendon and bone with sodium cyanoborohydride. Biochem J. 1977;163:339–46.
   PubMed Web of Science ®Google Scholar
• Knott L, Bailey AJ. Collagen cross-links in mineralizing tissues: a review of their chemistry, function, and clinical relevance. Bone. 1998;22:181–7.
   PubMed Web of Science ®Google Scholar
• Saito M, Marumo K. Collagen cross-links as a determinant of bone quality: a possible explanation for bone fragility in aging, osteoporosis, and diabetes mellitus. Osteoporos Int. 2010;21:195–214.
   PubMed Web of Science ®Google Scholar
• Shiraki M, Kuroda T, Tanaka S, Saito M, Fukunaga M, Nakamura T. Nonenzymatic collagen cross-links induced by glycoxidation (pentosidine) predicts vertebral fractures. J Bone Miner Metab. 2008;26:93–100.
   PubMed Web of Science ®Google Scholar
• Shiraki M, Kuroda T, Shiraki Y, Tanaka S, Higuchi T, Saito M. Urinary pentosidine and plasma homocysteine levels at baseline predict future fractures in osteoporosis patients under bisphosphonate treatment. J Bone Miner Metab. 2011;29:62–70.
   PubMed Web of Science ®Google Scholar
• Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998;280:1690–1.
   PubMed Web of Science ®Google Scholar